ISRCTN41474531已完成不适用
Randomised, controlled, double-blind clinical study on the effect of a functional milk-product on metabolism of men with diagnosed metabolic syndrome
Humana GmbH (Germany)0 个研究点目标入组 60 人开始时间: 2007年4月30日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Men, 45-70 years old, with a metabolic syndrome as defined by the International Diabetes Federation, 2006 (A new IDF worldwide definition of the metabolic syndrome: the rationale and the results - Diabetes Voice, Vol. 50 Issue 3, 2005)
排除标准
- •1. Participation in a clinical study with a medicament or a medicinal product within the last 30 days or simultaneous participation in another clinical examination
- •2. Intake of nitrate and/or calcium antagonists and/or alpha-blockers, which affect the blood pressure
- •3. Known metabolic or gastro-intestinal diseases, which affects the absorption, metabolism or excretion of food or food component
- •4. Condition after operation of the gastro-intestinal tract, which affect gastro-intestinal motility
- •5. Hemoglobin < 12 g/dL
- •6. Malfunction of blood coagulation or drugs, leading to malfunction of blood coagulating diabetes
- •7. Operation within the last 3 months, which still affects the current state of health
- •8. Illness of thyroid gland, which has metabolic and/or cardiovascular effect
- •9. Known hepatitis B, hepatitis C, HIV infection or chronic liver damage
- •10. Kidney insufficiency
- •11. Hypercalcaemia
- •12. Drug or alcohol abuse
- •13. Intake of drugs affecting the absorption, metabolism or excretion of food components or the gastro-intestinal
- •14. Intake of hormone preparations
- •15. Vegetarianism, anorexia, bulimia
- •16. Known milk protein allergy
研究者
相似试验
已完成
不适用
Effect of Functional milk product On the Metabolic Syndrome IIMetabolic syndromeNutritional, Metabolic, EndocrineISRCTN90960030Humana GmbH (Germany)240
进行中（未招募）
1 期
clinical study on the efficacy of infiltrative echo-guided therapy with hyaluronic acid (500-730 KDa) (HYALGAN®) versus saline solution in the conservative treatment of Achilles tendinopathy. Subjects will be randomly assigned to one of these two groups of treatment. Both evaluator and patients are unaware of the treatment assigned. In the open label extension, patients with persistent pain can receive a second cycle of Hyalgan.Achilles tendinopathyEUCTR2013-004117-40-ITFidia Farmaceutici SpA54
进行中（未招募）
1 期
ATVAC (Lactobacilli Therapeutic Vaccine study)Bacterial vaginosis (Nugent score 4 or above)EUCTR2013-002918-12-HUAmvac Kft
招募中
4 期
A randomized double-blind controlled clinical study on the effects of qishen yiqi dropping pills on exercise endurance and quality of life in patients with coronary heart disease after interventional therapyITMCTR2100004678China-Japan Friendship Hospital
尚未招募
1 期
A randomized double-blind controlled clinical study of Qiangxin compound in the treatment of type 2 cardiorenal syndrome under the hierarchical management mode of Integrated Chinese and Western MedicineITMCTR2000003812Traditional Chinese Medicine Hospital of Shanghai